Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001753926-25-001357
Filing Date
2025-08-19
Accepted
2025-08-19 16:20:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12444
2 EXHIBIT 1 g084929_ex-1.htm EX-1 6757
  Complete submission text file 0001753926-25-001357.txt   20991
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Subject) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87562 | Film No.: 251232069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123
Business Address 3053 FILLMORE ST. SUITE 256 SAN FRANCISCO CA 94123 415-999-2132
Ionic Ventures, LLC (Filed by) CIK: 0001769419 (see all company filings)

EIN.: 660889836 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G